The chronic diseases and rapid diagnostic test (RDT) are the trends for future medical care. Therefore, in 2010, Jiangsu ShiungDa Biotechnology Company (SDBIO), set up the laboratories for development in Beijing and Taiwan. Many talented people were widely called for developing and in-tegration in vitro diagnostic reagents. Through several years, our